Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000947119 | SCV001093288 | likely benign | not provided | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV000947119 | SCV005221683 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Natera, |
RCV001276128 | SCV001461979 | uncertain significance | Achromatopsia | 2020-01-24 | no assertion criteria provided | clinical testing | |
Clinical Genetics, |
RCV000947119 | SCV001921952 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000947119 | SCV001974592 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Prevention |
RCV004733096 | SCV005363062 | likely benign | CNGB3-related disorder | 2024-08-27 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |